*Some Market data delayed by 15 mins.

Inhibrx Biosciences, Inc. Common Stock

Symbol: INBX (NASDAQ)
34.15 ▲ (0.49%) 0.165

Company Description:
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Key Stats
  • Today's Open: $34
  • Today's High: $34.78
  • Today's Low: $33.421
  • Today's Volume: 18.00K
  • Yesterday Close: $33.98
  • Yesterday High: $34.87
  • Yesterday Low: $32.54
  • Yesterday Volume: 119.83K
  • Last Min Volume: 4
  • Last Min High: $34.145
  • Last Min Low: $34.145
  • Last Min VWAP: $34.145
Company Profile
  • Name: Inhibrx Biosciences, Inc. Common Stock
  • Website: https://www.inhibrx.com
  • Listed Date: 2024-05-28
  • Location: LA JOLLA, CA
  • Market Status: Active
  • CIK Number: 0002007919
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $492.21M
  • Round Lot: 100
  • Outstanding Shares: 14.49M
  • Asset Type: CS
RECENT FILINGS FOR INBX
Filing Date Filing Type Format
2025-08-13 8-K View
2025-08-13 10-Q View
2025-06-04 EFFECT View
2025-06-02 POS AM View
2025-05-29 4 View
2025-05-29 4 View
2025-05-29 4 View
2025-05-29 4 View
2025-05-28 424B3 View
2025-05-28 8-K View
2025-05-14 424B3 View
2025-05-14 8-K View
2025-05-14 10-Q View
2025-04-18 EFFECT View
2025-04-17 POS AM View
2025-04-17 ARS View
2025-04-16 DEFA14A View
2025-04-16 DEF 14A View
2025-04-02 4 View
2025-04-02 4 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.